{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:27:26Z","timestamp":1793636846292,"version":"4.5.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.thromres.2026.109868","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:13:08Z","timestamp":1791501188000},"page":"109868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Limitations of protamine sulphate for in vitro neutralization of unfractionated heparin in thrombin generation assays"],"prefix":"10.1016","volume":"266","author":[{"given":"Mariangela","family":"Costanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Bertaggia Calderara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime G.","family":"Zermatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2026.109868_bb0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/a-1200-0417","article-title":"Usefulness of thrombin generation","volume":"40","author":"Tripodi","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2026.109868_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2021.02.026","article-title":"Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability","volume":"201","author":"van de Berg","year":"2021","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.thromres.2026.109868_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ijlh.13735","article-title":"The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy","volume":"44","author":"Benoit","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"issue":"11","key":"10.1016\/j.thromres.2026.109868_bb0020","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1182\/blood-2002-08-2400","article-title":"Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass","volume":"101","author":"Chandler","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2026.109868_bb0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2013.12.017","article-title":"Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery","volume":"133","author":"Bosch","year":"2014","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109868_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1213\/ANE.0b013e3181e9ed15","article-title":"The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations","volume":"111","author":"Bolliger","year":"2010","journal-title":"Anesth. Analg."},{"issue":"2","key":"10.1016\/j.thromres.2026.109868_bb0035","first-page":"251","article-title":"Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial","volume":"116","author":"Meesters","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2026.109868_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/aca.aca_117_23","article-title":"Protamine and heparin interactions: a narrative review","volume":"27","author":"Crivellari","year":"2024","journal-title":"Ann. Card. Anaesth."},{"issue":"4","key":"10.1016\/j.thromres.2026.109868_bb0045","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/ja109699s","article-title":"Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management","volume":"133","author":"Maurer","year":"2011","journal-title":"J. Am. Chem. Soc."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826002872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:47:16Z","timestamp":1793634436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826002872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":9,"alternative-id":["S0049384826002872"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109868","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitations of protamine sulphate for in vitro neutralization of unfractionated heparin in thrombin generation assays","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109868"}}